Saturday - October 10, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Pine Pharmaceuticals
October 06, 2026
WASHINGTON, Oct. 6 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Pine Pharmaceuticals LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Alfonse J. Muto PharmD, Owner, Pine Pharmaceuticals, LLC, 355 Riverwalk Parkway, Tonawanda, NY 14150-5837, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products